XML 60 R29.htm IDEA: XBRL DOCUMENT
v3.23.1

COMMITMENTS AND CONTINGENCIES (Detail Textuals) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2022 USD ($)
Patent Transfer Agreement [Member] |
Commitments [Line Items] |
Percentage of net revenues | 3.00%
D.N.A Biomedical Solutions Ltd [Member] | Joint Venture Agreement [Member] |
Commitments [Line Items] |
Amount of investment in entity | $ 600
D. N. A Biomedical Solutions Ltd And Oramed Ltd [Member] | Joint Venture Agreement [Member] |
Commitments [Line Items] |
Percentage of ownership of entity acquired | 50.00%
Government of Israel [Member] |
Commitments [Line Items] |
Percentage sales of products developed from projects in first three years, from commencement of revenues | 3.00%
Percentage sales of products developed from projects subsequent three years | 4.00%
Percentage sales of products developed from projects commencing the seventh year up to 100% of amount of grant received | 5.00%
Total royalty amount payable | $ 460
Percentage of each payment received from Amgen | 5.38%
Royalty amount paid | $ 83

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | entx_CommitmentsLineItems
Namespace Prefix: | entx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the amount paid for royalty to IIA. + References No definition available. + Details
Name: | entx_PaymentOfRoyaltyGuaranteesCommitments
Namespace Prefix: | entx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the percentage of each payment received from Amgen. + References No definition available. + Details
Name: | entx_RoyaltyGuaranteesCommitmentsPercentageOfEachPaymentReceivedFromAmgen
Namespace Prefix: | entx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of net revenues. + References No definition available. + Details
Name: | entx_RoyaltyGuaranteesCommitmentsPercentageOfNetRevenues
Namespace Prefix: | entx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage sales of products developed from projects commencing the seventh year. + References No definition available. + Details
Name: | entx_RoyaltyGuaranteesCommitmentsPercentageSalesOfProductsDevelopedFromProjectsCommencingSeventhYear
Namespace Prefix: | entx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage sales of products developed from projects in first three years, from commencement of revenues. + References No definition available. + Details
Name: | entx_RoyaltyGuaranteesCommitmentsPercentageSalesOfProductsDevelopedFromProjectsInFirstThreeYearsFromCommencementOfRevenues
Namespace Prefix: | entx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage sales of products developed from projects subsequent three years. + References No definition available. + Details
Name: | entx_RoyaltyGuaranteesCommitmentsPercentageSalesOfProductsDevelopedFromProjectsSubsequentThreeYears
Namespace Prefix: | entx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the amount invested in the entity. + References No definition available. + Details
Name: | entx_SaleOfStockAmountOfInvestment
Namespace Prefix: | entx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the percentage of ownership of entity acquired. + References No definition available. + Details
Name: | entx_SaleOfStockPercentageOfOwnershipOfEntityAcquired
Namespace Prefix: | entx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount the entity has committed to make for future royalty guarantees. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 928 -SubTopic 440 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013 + Details
Name: | us-gaap_RoyaltyGuaranteesCommitmentsAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | entx_AgreementAxis=entx_PatentTransferAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=entx_DnaBiomedicalSolutionsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | entx_AgreementAxis=entx_JointVentureAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=entx_DnaBiomedicalSolutionsLtdAndOramedLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=us-gaap_GovernmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |